Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance. This is page number 7.
Order by Relevance | Date
Total 2010 results found since Jan 2013.
Recombinant zoster vaccine coverage in the United States: An analysis of claims-based data
This study quantifies RZV coverage and assesses predictors for RZV vaccination using a U.S. claims database. Univariate linear regression provided annual prevalence of RZV vaccination and multivariable logistic regression provided ORs and 95% CIs for associations between predictors and RZV vaccination. A total of 4,124,315 individuals (19,080,914 person-years) were included in this study. Since receiving FDA approval for the prevention of HZ, RZV coverage (of at least one dose) has reached approximately 17% within the eligible U.S. population by January 2021, although significant disparities between demographic groups were...
Source: Vaccine - May 7, 2023 Category: Allergy & Immunology Authors: Chad Y Lewis Kunal Mishra Yuwei Sun Samantha J Sechrist Benjamin F Arnold Nisha R Acharya Source Type: research
Improving Adherence to National Recommendations for Zoster Vaccination Through Simple Interventions.
CONCLUSIONS:: Interventions implemented during the study led to an increase in physicians' basic knowledge of the HZ vaccine and an increase in usage at the affiliated pharmacy.
PMID: 24901974 [PubMed - as supplied by publisher]
Source: Herpes - June 4, 2014 Category: Infectious Diseases Authors: Elkin ZP, Cohen EJ, Goldberg JD, Li X, Castano E, Gillespie C, Haberman I, Jung JJ, Zabar S, Park L, Perskin MH Tags: Eye Contact Lens Source Type: research
Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project.
CONCLUSION: Electronic identification of vaccine eligibility and BPA significantly improved HZ vaccination rates. The process required minimal modification of clinic work flow and did not burden the physician's time, and has the potential for self-sustainability and generalizability.
PMID: 28042124 [PubMed - in process]
Source: J Rheumatol - December 31, 2016 Category: Rheumatology Authors: Sheth H, Moreland L, Peterson H, Aggarwal R Tags: J Rheumatol Source Type: research
Chickenpox Outbreak Hits North Carolina School With High Vaccination Exemption Rate
A North Carolina school where a high concentration of families claim religious exemption from vaccines is facing the state’s worst chickenpox outbreak in more than 20 years.
The chickenpox outbreak has affected 36 students at Asheville Waldorf School, health officials with Buncombe County said. The outbreak ranks as North Carolina’s largest since a chickenpox vaccine became available more than 20 years ago, the Asheville Citizen Times reports.
The Asheville Waldorf School has one of the highest rates in the state of families who opt out of vaccines based on religious beliefs, according to data from North Caroli...
Source: TIME: Health - November 20, 2018 Category: Consumer Health News Authors: Mahita Gajanan Tags: Uncategorized chickenpox North Carolina onetime vaccines Source Type: news
A Fourth COVID-19 Vaccine, From Novovax, Passed a Key Stage in the Authorization Process
American adults who haven’t yet gotten vaccinated against COVID-19 may soon get another choice, as advisers to the Food and Drug Administration on Tuesday backed a more traditional type of shot.
Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. It’s made with more conventional technology than today’s dominant Pfizer and Moderna shots and the lesser-used Johnson & Johnson option.
Novavax shots are already available in Australia, Canada, parts of Europe and multiple other countries, either for initial va...
Source: TIME: Health - June 8, 2022 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
Adult Vaccination as a Protective Factor for Dementia: A Meta-Analysis and Systematic Review of Population-Based Observational Studies
CONCLUSION: Routine adult vaccinations are associated with a significant reduction in dementia risk and may be an effective strategy for dementia prevention. Further research is needed to elucidate the causal effects of this association and the underlying mechanisms.PMID:35592323 | PMC:PMC9110786 | DOI:10.3389/fimmu.2022.872542
Source: Herpes - May 20, 2022 Category: Infectious Diseases Authors: Xinhui Wu Haixia Yang Sixian He Ting Xia Diang Chen Yexin Zhou Jin Liu MengSi Liu Zhen Sun Source Type: research
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights
CONCLUSION: This study indicates that the occurrence of VZV reactivation is clinically relevant. However, our findings suggest that COVID-19 vaccination is safe, and remains strongly recommended.PMID:35931613 | PMC:PMC9340059 | DOI:10.1016/j.ejim.2022.07.022
Source: European Journal of Internal Medicine - August 5, 2022 Category: Internal Medicine Authors: Raquel Martinez-Reviejo Sofia Tejada Ganiyat A R Adebanjo Camilla Chello Miriam C Machado Francesca R Parisella Magda Campins Antonella Tammaro Jordi Rello Source Type: research
Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials
Front Immunol. 2022 Sep 23;13:999704. doi: 10.3389/fimmu.2022.999704. eCollection 2022.ABSTRACTSystemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that frequently affects the kidneys, known as lupus nephritis (LN). Such patients are treated with antimalarials, corticosteroids or immunosuppressive drugs, and more recently, target-specific biological drugs. Although efficacy of these therapies improved SLE-related outcomes, SLE remains associated with higher rates of infections. Here, we performed a comprehensive systemic review of infectious complications in clinical trials covering drug interventions f...
Source: Herpes - October 10, 2022 Category: Infectious Diseases Authors: Stefanie Steiger Louisa Ehreiser Juliane Anders Hans-Joachim Anders Source Type: research
